文献速递认知障碍与痴呆

「阿尔茨海默病」简史:同一名称下的多重含义

A brief history of "Alzheimer disease": Multiple meanings separated by a common name.
PubMed 文献 · Neurology · 2019-04-26

本文梳理「阿尔茨海默病(AD)」诊断标签的多重含义:1984年提出的「很可能AD」代表临床病理实体,后衍生出通俗用法(指所有非其他原因痴呆),1990年代神经病理学家转向纯病理定义,近十年生物标志物使生前病理生物学诊断成为可能;各定义不可互换,仅病理生物学定义无歧义。

要点

  • 「很可能AD」原指临床诊断的获得性进展性遗忘性痴呆且无其他病因证据,假设其与淀粉样斑块和tau神经原纤维缠结病理敏感关联。
  • 通俗用法将AD泛化为所有非其他临床明显原因的痴呆,源于公众对晚年认知障碍的关注。
  • 神经病理学定义仅基于尸检中足够的神经炎性斑块和神经原纤维缠结负荷,不论生前临床状态。

核心结论

  • AD诊断标签存在多种不同含义,各定义不可互换,仅病理生物学定义无歧义。

研究设计与样本

  • 本文为历史综述,回顾AD诊断标签的演变,未报告系统检索范围或样本量。

主要发现

  • 1984年引入的「很可能AD」指临床诊断的获得性进展性遗忘性痴呆且无其他病因证据,假设其与淀粉样斑块和tau缠结病理敏感关联。
  • 临床病理模型被简略改编用于人群研究和一般临床实践,但「很可能」所暗示的不确定性常被忽视。
  • 通俗用法中AD代表所有非其他临床明显原因的痴呆。
  • 1990年代神经病理学家确定AD定义完全基于尸检中足够的神经炎性斑块和神经原纤维缠结负荷,不论生前临床状态。
  • 近十年液体和影像生物标志物使生前病理生物学诊断成为可能,凸显临床病理模型、通俗用法与病理生物学模型间的分歧。

临床怎么用

  • 临床使用「AD」一词时应明确所指定义(临床病理、通俗或病理生物学),避免含义混淆。

局限性

  • 本文为历史综述,未报告系统检索策略或纳入标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The field of Alzheimer disease (AD) has a nosologic problem: The diagnostic label "Alzheimer disease" has several distinctive meanings. The term probable AD was introduced in 1984 to designate a clinically diagnosed acquired and progressive amnestic dementia for which there was no evidence for another etiology. Probable AD represented a clinicopathologic entity that assumed a specific and sensitive linkage between amnestic dementia and the neuropathology of β-amyloid-containing neuritic plaques and tau-containing neurofibrillary tangles. The clinicopathologic model represented by probable AD was adapted in abbreviated form for population-based studies and general clinical practice, although the uncertainty connoted by "probable" was often overlooked. Representing the growing public awareness of later life cognitive impairment, a vernacular meaning of AD arose out of the clinicopathologic model in which AD represented all dementia not due to another clinically apparent cause. In contrast, by the 1990s, neuropathologists settled on a definition of AD based entirely on a sufficient burden of neuritic plaques and neurofibrillary tangles at postmortem examination, regardless of antemortem clinical status. In the last decade, the availability of fluid and imaging biomarkers that measure β-amyloid and tau abnormalities has enabled antemortem pathobiological diagnoses, highlighting the divide between the clinicopathologic model, the vernacular usage, and the pathobiological models. Each definition has value. However, the meanings of AD as defined by each of these models are not interchangeable. The pathobiological one is the only one that is unambiguous.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Knopman DS, Petersen RC, Jack CR, et al. A brief history of "Alzheimer disease": Multiple meanings separated by a common name. Neurology. 2019. PMID: 31028129. doi:10.1212/WNL.0000000000007583

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。